Non‐small cell lung cancer in China
P Chen, Y Liu, Y Wen, C Zhou - Cancer Communications, 2022 - Wiley Online Library
In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors
for lung cancer include tobacco use, family history, radiation exposure, and the presence of …
for lung cancer include tobacco use, family history, radiation exposure, and the presence of …
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Cancer is one of the major diseases that cause a high number of deaths globally. Of the
major types of cancers, lung cancer is known to be the most chronic form of cancer in the …
major types of cancers, lung cancer is known to be the most chronic form of cancer in the …
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
J Timar, K Kashofer - Cancer and Metastasis Reviews, 2020 - Springer
RAS mutation is the most frequent oncogenic alteration in human cancers. KRAS is the most
frequently mutated followed by NRAS. The emblematic KRAS mutant cancers are …
frequently mutated followed by NRAS. The emblematic KRAS mutant cancers are …
Advances in lung cancer treatment using nanomedicines
A Sharma, D Shambhwani, S Pandey, J Singh… - ACS …, 2022 - ACS Publications
Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor
prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of …
prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of …
Precision diagnosis and treatment for advanced non–small-cell lung cancer
M Reck, KF Rabe - New England Journal of Medicine, 2017 - Mass Medical Soc
Smoking cessation has reduced the incidence of lung cancer. The authors of this review
discuss recent progress in diagnostic and treatment approaches, including molecular …
discuss recent progress in diagnostic and treatment approaches, including molecular …
Worldwide prevalence of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis
B Melosky, K Kambartel, M Haentschel… - Molecular Diagnosis & …, 2022 - Springer
Background Identification of variable epidermal growth factor receptor (EGFR) gene
mutations in non-small cell lung cancer (NSCLC) is important for the selection of appropriate …
mutations in non-small cell lung cancer (NSCLC) is important for the selection of appropriate …
Fibroblast growth factor receptors as treatment targets in clinical oncology
M Katoh - Nature reviews Clinical oncology, 2019 - nature.com
FGFRs are receptor tyrosine kinases with a role in several biological processes, such as the
regulation of development and tissue repair. However, alterations in FGFRs 1–4, such as …
regulation of development and tissue repair. However, alterations in FGFRs 1–4, such as …
Precision medicine for human cancers with Notch signaling dysregulation
M Katoh, M Katoh - International journal of molecular …, 2020 - spandidos-publications.com
Abstract NOTCH1, NOTCH2, NOTCH3 and NOTCH4 are transmembrane receptors that
transduce juxtacrine signals of the delta‑like canonical Notch ligand (DLL) 1, DLL3, DLL4 …
transduce juxtacrine signals of the delta‑like canonical Notch ligand (DLL) 1, DLL3, DLL4 …
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
JR Brahmer, R Govindan, RA Anders… - … for immunotherapy of …, 2018 - Springer
Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small cell
lung cancer (NSCLC) accounting for over 85% of all cases. Until recently, chemotherapy …
lung cancer (NSCLC) accounting for over 85% of all cases. Until recently, chemotherapy …
The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA
J Li, Y Han, H Zhang, Z Qian, W Jia, Y Gao… - Biochemical and …, 2019 - Elsevier
Lung cancer is one of the leading causes of cancer-related death in developed countries.
Despite decades of intensive efforts to comate this malignant disease, the prognosis of lung …
Despite decades of intensive efforts to comate this malignant disease, the prognosis of lung …